Freestyle libre 3 plus sensors
Ended Awarded Last action
- Contract number
- SPE2DR26FM39A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $74,321
Award facts
- Contract value 100% obligated
- $74,321.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $74,321.30 delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 13, 2026, for the supply of FreeStyle Libre 3 Plus Sensors, with an ultimate completion date of January 14, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a subsidiary of Cencora, Inc., and serves as a critical pharmaceutical distributor for federal medical procurement. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which provides a comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs worldwide.
The FreeStyle Libre 3 Plus Sensors are continuous glucose monitoring devices essential for diabetes management across military treatment facilities and veteran healthcare programs supported by the Defense Health Agency and other federal medical systems. Amerisourcebergen's extensive federal contract portfolio demonstrates its capability to efficiently fulfill specialized medical device requirements through competitive procurement processes. The company's participation in the DLA Pharmaceutical Prime Vendor Global Program underscores its role as a key supplier of both brand-name and generic pharmaceuticals, medical devices, vaccines, and related healthcare commodities to support the Department of Defense's medical supply chain globally.
Quick answers
Who was awarded contract SPE2DR26FM39A?
SPE2DR26FM39A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FM39A worth?
The government has obligated $74,321 on SPE2DR26FM39A.
Is contract SPE2DR26FM39A an order under another contract?
Yes. SPE2DR26FM39A is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM39A competed?
The extent of competition for SPE2DR26FM39A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award